date/time interval
- December 1, 2022 - September 30, 2024
Development of a platform for high throughput drug screening on CTC-derived organoid in breast and colorectal cancer
Grant
Overview
administered by
sponsor award ID
- NFCR 227177-01
Affiliation
contributor
- Cristofanilli, Massimo Principal Investigator 2022 - 2023